Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Documentation
Home
>
Investors & media
>
Documentation
Year
All
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Documentation type
All
General Assembly
Financial statements and reports
Regulated information
Corporate presentations
General meetings
23 April 2025
General Assembly, General meetings
Rapport des commissaires aux comptes sur les états financiers annuels 2024 en normes françaises
Open in new window
23 April 2025
General Assembly, General meetings
AGM 2025 – Board nominees
Open in new window
23 April 2025
General Assembly, General meetings
Report on capital reduction
Open in new window
23 April 2025
General Assembly, General meetings
2025 AGM – Notice and Convening Brochure
Open in new window
23 April 2025
General Assembly, General meetings
Global delegation report
Open in new window
23 April 2025
General Assembly, General meetings
Preliminary Notice of the General Meeting 2025
Open in new window
23 April 2025
General Assembly, General meetings
Report on CAPITAL INCREASE RESERVED FOR EMPLOYEES
Open in new window
23 April 2025
General Assembly, General meetings
Free shares Report
Open in new window
23 April 2025
General Assembly, General meetings
Stock Option Report
Open in new window
23 April 2025
General Assembly, General meetings
OCA Report
Open in new window
1
2
3
4
5
6
…
23
View next 9 articles
Go back to the page of the page